A Personalized Mass Spectrometry–Based Assay to Monitor M-Protein in Patients with Multiple Myeloma (EasyM)

PURPOSE: M-protein is a well-established biomarker used for multiple myeloma monitoring. Current improvements in multiple myeloma treatment created the need to monitor minimal residual disease (MRD) with high sensitivity. Measuring residual levels of M-protein in serum by MS was established as a sen...

Descripción completa

Detalles Bibliográficos
Autores principales: Liyasova, Mariya, McDonald, Zac, Taylor, Paul, Gorospe, Kathleen, Xu, Xin, Yao, Chenyu, Liu, Qixin, Yang, Liqiang, Atenafu, Eshetu G., Piza, Giovanni, Ma, Bin, Reece, Donna, Trudel, Suzanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2021
Materias:
Precision Medicine and Imaging
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9401514/
https://www.ncbi.nlm.nih.gov/pubmed/34210683
http://dx.doi.org/10.1158/1078-0432.CCR-21-0649

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9401514/
https://www.ncbi.nlm.nih.gov/pubmed/34210683
http://dx.doi.org/10.1158/1078-0432.CCR-21-0649

Ejemplares similares